SEC Form 4 · accession 0001209191-15-010389
Auspex Pharmaceuticals, Inc. · ASPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Feb 4, 2015
Accepted (ET)
Feb 6, 2015 · 4:59 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001454189
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 4, 2015 | S | 48,750 | $59.30 | D | 3,209,271 | D | |
| Common Stock | Feb 5, 2015 | S | 12,578 | $59.51 | D | 3,196,693 | D | |
| Common Stock | Feb 6, 2015 | S | 29,522 | $59.48 | D | 3,167,171 | D | |
| Common Stock | Feb 4, 2015 | S | 1,250 | $59.30 | D | 82,339 | I | By: CMEA Ventures VII (Parallel) LP |
| Common Stock | Feb 5, 2015 | S | 322 | $59.51 | D | 82,017 | I | By: CMEA Ventures VII (Parallel) LP |
| Common Stock | Feb 6, 2015 | S | 757 | $59.48 | D | 81,260 | I | By: CMEA Ventures VII (Parallel) LP |
Table II — derivative securities
No Table II lines on this filing.